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accessible obstructions of more than 50%
of the pulmonary vascular bed.3
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Reply to the Editor:
We appreciate the attention that Dr Riedel
has paid to our article. He brings up several
points that deserve clarification.
First, selection criteria for pulmonary
endarterectomy are multiple, and deter-
mination of candidacy for pulmonary
endarterectomy is based on a composite
of factors. Our selection criteria for sur-
gery include but are not limited to just
New York Heart Association (NYHA)
class III and IV patients. We offer pul-
monary endarterectomy to patients with
NYHA class I and II disease, although
only 1 in our series was in NYHA class I.
The long-term survival of patients with
untreated chronic thromboembolic pul-
monary hypertension, irrespective of
symptoms, is poor.1 In our hands, the
mortality associated with pulmonary end-
arterectomy (4.5%) is much less than the
published mortality associated with un-
treated thromboembolic pulmonary hy-
pertension (32.6% in 1 series with an
average follow-up of 18.7 months2). In
our experience, pulmonary endarterec-
tomy is not only associated with im-
proved long-term survival but also a bet-
ter quality of life for patients who
previously suffered from this disease.3
Furthermore, we have become increas-
ingly aware that the remaining open pul-
monary vascular bed after thromboem-
bolic occlusion can become irreparably
damaged by prolonged exposure to the
flow and pressure changes occasioned by
vascular occlusion in other areas.4 For
these reasons, we believe that pulmonary
endarterectomy should be offered to all
patients with thromboembolic pulmonary
hypertension, including those with less
clinical symptomatology.
Second, patients in group 1 of our
study were comprised of individuals with
chronic pulmonary hypertension who had
fibrotic thromboembolic obstruction of
their main and/or lobar pulmonary arter-
ies as well as fresh clot that occurred
either as a result of recurrent pulmonary
emboli or as a secondary consequence of
this obstructive process (see Figure 1).
No amount of anticoagulation or throm-
bolytic therapy would have altered the
distal fibrotic obstruction that was re-
sponsible for the patients’ pulmonary hy-
pertension. Incidentally, proximal clot
propagation occurs even in the setting of
therapeutic anticoagulation, as more than
80% of the group 1 patients referred to us
for operation had been on coumadin for a
period of longer than 3 months. We do
not treat patients with acute pulmonary
embolism with pulmonary endarterecto-
my; this is a different disease.
Third, although we have performed
more than 1600 pulmonary endarterecto-
mies in the last 10 years at the University
of California, San Diego, we still do not
have a completely foolproof method of
determining location of pulmonary vas-
cular obstructive disease in all patients.
We have found that pulmonary angiogra-
phy is the imaging modality that provides
the best preoperative assessment of
thromboembolic obstruction. However,
using a combination of assessments, in-
cluding angiography, angioscopy, venti-
lation-perfusion scanning, spiral com-
puted tomography (CT) scanning, and
3-dimensional CT angiography, there are
still a few patients in whom disease lo-
cation is not diagnosed with certainty
prior to surgery. It is precisely this small
group of patients (with distal small vessel
disease, or “primary” pulmonary hyper-
tension, type 4) that represent our treat-
ment failures and in retrospect would not
have been operated on. These patients,
incidentally, had failed other therapeutic
measures to reduce their pulmonary pres-
sures.
Fourth, Table 3 in our paper addresses
1-month survival data, while Table 4 lists
complications we have seen in the periop-
erative period after this operation. We re-
port complications we have seen with this
operation, and they represent a rate similar
to (or even less than) the complication rates
seen for other major cardiovascular opera-
tions. Rather than operating upon lower
risk patients, in recent years we have ex-
panded the eligible patient population for
pulmonary endarterectomy to include
older, sicker individuals, often with other
concomitant heart disease. In any event,
postoperative complications per se are not
a reason to exclude patients from a lifesav-
ing operation; rather, they represent an ac-
curate depiction of our clinical experience
with the surgical treatment of chronic
thromboembolic disease over a wide spec-
trum of patient age groups and disease se-
verity.
Finally, although comparisons be-
tween medically managed chronic throm-
boembolic disease and pulmonary endar-
terectomy have not been systematically
made in prospective randomized trials,
we believe that such trials would essen-
tially be unethical, given the disparity in
published survival statistics. The cumu-
lative data from our institution leave no
doubt that pulmonary endarterectomy is
the superior treatment choice for man-
agement of pulmonary hypertension
caused by chronic thromboembolic dis-
ease to the lungs.
Patricia A. Thistlethwaite, MD, PhD
Stuart W. Jamieson, MB, FRCS
Division of Cardiothoracic Surgery
University of California, San Diego
San Diego, CA 92103-8892
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Tuberculous aneurysm of the aortic
arch
To the Editor:
We read with interest the recent article of
Hatem and colleagues.1 We report here an
additional surgical case of tuberculous an-
eurysm of the thoracic aorta with some
resemblance to their case report.
A 52-year-old man was admitted to the
hospital. He was previously healthy and
reported a 6-week history of fever, malaise,
and weight loss. On admission, results of
cardiothoracic examination were normal,
and all upper and lower extremity pulses
were palpable. The chest radiograph
showed a diffuse micronodular pattern in
both lung fields. Bronchoscopic lung ex-
amination and biopsy revealed granuloma-
tous pneumonitis with the presence of
Langhans cells. The Ziehl-Neelsen test re-
sult was positive. The diagnosis was tuber-
culosis, and subsequently treatment with
antituberculous agents was administered.
Results of blood and urine analyses were
normal. Investigation for HIV infection
had negative results. Computed tomo-
graphic scan (Figure 1, A) and digital aor-
tography (Figure 1, B) disclosed a localized
aneurysm in the aortic arch. A diagnosis of
mycotic aneurysm of the thoracic aorta was
reached. The patient underwent operation
on May 3, 1994. A left thoracotomy
through the fourth intercostal space was
accomplished, and an inflammatory aneu-
rysm of the distal aortic arch was exposed.
The left upper lobe of the lung was in-
volved in the process and was dissected off
the aneurysm. The left subclavian artery,
distal descending thoracic aorta, and part of
the aneurysm were isolated. During dissec-
tion of the proximal aortic arch, the aneu-
rysm ruptured, with massive cataclysmic
hemorrhage. Despite clamping of the aortic
arch, rapid transfusion, and other maneu-
vers, the patient exsanguinated and died in
the operating room.
The upper left lung, aortic arch, and
mediastinal lymph nodes were sent for
pathologic study. The histopathologic ex-
amination of the lung and nodes was con-
sistent with tuberculosis, as was that of the
walls of the aorta and aneurysm, which
showed an inflammatory pattern with lym-
phocytes, histiocytes, plasmatic cells, and
giant cells of Langhans (Figure 1, C).
We agree with Hatem and colleagues1
regarding the extreme rarity of tuberculous
aneurysm of the thoracic aorta. In 1996
Izekawa coworkers2 published a case re-
port and in a review collected 32 additional
surgical cases. Since then, a few more
cases have been reported.3,4 We believe
that our case reported here may be useful
and of interest to complete the scarce bib-
liographic list of this uncommon entity.
Cipriano Abad, MD
Department of CardioVascular Surgery
Hospital Universitario de GC Dr Negrin
Las Palmas de Gran Canaria, Spain
Paloma Santamaria, MD
Department of Pathology
Hospital Universitario de GC Dr Negrin
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Figure 1. A, CT scan shows aneurysm in
aortic arch. B, Digital aortography demon-
strates saccular aneurysm in aortic arch.
Remainder of thoracic aorta is angio-
graphically normal. C, Arterial wall of aor-
tic arch and aneurysm showing inflamma-
tory signs with lymphocytes, histiocytes,
plasmatic cells, and giant cells of Lang-
hans type (hematoxylin and eosin, original
magnification 200).
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